Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.410
-0.020 (-0.45%)
Sep 8, 2026, 11:10 AM EDT - Market open
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $210.57 million as of September 8, 2026. Its market cap has increased by 1,183.94% in one year.
Market Cap
210.57M
Enterprise Value
195.30M
1-Year Change
1,183.94%
Ranking
Category
Stock Price
$4.41
ChartMarket Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has increased from $110.60M to $210.57M, an increase of 90.39%. That is a compound annual growth rate of 5.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 210.57M | 649.35% |
| Dec 31, 2025 | 28.10M | 81.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
| Jul 1, 2014 | 110.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coherus Oncology | 219.39M |
| Armata Pharmaceuticals | 217.14M |
| Voyager Therapeutics | 216.28M |
| PepGen | 215.40M |
| Protalix BioTherapeutics | 215.13M |
| Corbus Pharmaceuticals Holdings | 214.30M |
| Nkarta | 209.14M |
| NovaBridge Biosciences | 208.80M |